Gene Symbol | C1QTNF5 |
---|---|
Entrez Gene | 114902 |
Alt Symbol | CTRP5 |
Species | Human |
Gene Type | protein-coding |
Description | C1q and tumor necrosis factor related protein 5 |
Other Description | C1q TNF-alpha-related protein 5|complement C1q tumor necrosis factor-related protein 5|myonectin |
Swissprots | Q9BXJ0 Q8N6P2 Q335M2 Q9UFX4 B0YJ35 A6NDD3 |
Accessions | ACA06014 EAW67481 EAW67482 Q9BXJ0 AF086482 AF329841 AAK17965 AY358383 AAQ88749 DB534759 NM_001278431 NP_001265360 NM_015645 NP_056460 |
Subcellular Location | Secreted {ECO:0000305}. |
CTRP5 CRISPR/Cas9 KO Plasmid (h) - sc-407181 from Santa Cruz Biotechnology
|
||||||||
CTRP5 HDR Plasmid (h) - sc-407181-HDR from Santa Cruz Biotechnology
|
||||||||
CTRP5 Double Nickase Plasmid (h) - sc-407181-NIC from Santa Cruz Biotechnology
|
||||||||
CTRP5 Double Nickase Plasmid (h2) - sc-407181-NIC-2 from Santa Cruz Biotechnology
|
||||||||
CTRP5 CRISPR Activation Plasmid (h) - sc-407181-ACT from Santa Cruz Biotechnology
|
||||||||
CTRP5 CRISPR Activation Plasmid (h2) - sc-407181-ACT-2 from Santa Cruz Biotechnology
|
||||||||
CTRP5 Lentiviral Activation Particles (h) - sc-407181-LAC from Santa Cruz Biotechnology
|
||||||||
CTRP5 Lentiviral Activation Particles (h2) - sc-407181-LAC-2 from Santa Cruz Biotechnology
|
||||||||
CTRP5 siRNA (h) - sc-77053 from Santa Cruz Biotechnology
|
||||||||
CTRP5 shRNA Plasmid (h) - sc-77053-SH from Santa Cruz Biotechnology
|
||||||||
CTRP5 shRNA (h) Lentiviral Particles - sc-77053-V from Santa Cruz Biotechnology
|
||||||||
CompoZr® Knockout ZFN Kit - CKOZFN4694 from Sigma-Aldrich
|
||||||||
CompoZr® Knockout ZFN Kit, ZFN plasmid only - CKOZFND4694 from Sigma-Aldrich
|
||||||||
C1QTNF5 siRNA (Human) - CRJ4411 from Cohesion Biosciences
|
||||||||
C1QTNF5 - MBS8200569 from MyBioSource
|
||||||||
shRNA set against Human C1QTNF5 (NM_015645.3) - SHH250813 from Creative biogene
|
||||||||
C1QTNF5 shRNA Plasmid (Human) - CHJ4411 from Cohesion Biosciences
|
||||||||
C1QTNF5 miRNA 3'UTR clone - MiUTR3H-10199 from Creative biogene
|
||||||||